Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Business > Marketing > How to Get Buy-In for Important Marketing and Branding Initiatives

Tags

  • involved
  • decision
  • information
  • creative solution
  • companies involved

  • Links

  • The Secret To Creating a Great Life - Know What You Don't Want
  • Use Native American Drums As Rustic Furniture
  • Training Your Mind For Better Business and Leisure
  • Just Other Articles - How to Get Buy-In for Important Marketing and Branding Initiatives

    What’s the best way to get decision makers all on the same page when important marketing and communications outcomes are at stake? What can you do when design and branding decisions need to be made by a group – especially by a group of executives who
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    don’t necessarily value the creative process?

    It’s important to help people make connections.

    A method is needed to help make the connection between the unspoken, emotional aspects of people’s feelings and perceptions about a company, product,
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    or service, and the visual representation of it – a tricky thing to understand for most people.

    The problem

    Often, brands, logos, and graphics are created by outside marketing firms without executive level input, and are based on
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    a designer’s interpretation of communication value. There is often a substantial gap between the designer’s natural understanding of the creative process and the lack of this understanding on the part of the individuals in the company who are purc
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    hasing the creative solution. This gap causes company management to relate to the visual representations on the surface, out of context, and with knee-jerk reactions—even if they understand the objectives used by the designer to develop the solut
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ion. In the absence of a process to bridge this gap, personal likes and dislikes are used to evaluate the appropriateness of the creative solution, as individuals have little else on which to base their reactions. When you’ve got a group of decision
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    makers to satisfy, this is bad news. As everyone’s personal likes and dislikes are going to be different, coming to agreement can be very difficult.

    The solution

    The solution is to bring the people responsible for the approval and ultimate u
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    se of the visual solution into the creative process at the beginning and have them involved in the creative development. With the group’s participation, everyone’s input is prioritized and put into context, and relationships between graphic elements
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    and their purpose can be explored. This process helps to bridge the communication gap and match specific objectives with visual interpretation and/or wording in a way that makes use of each person’s valuable insight about the organization, its
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    products and/or services, and its objectives for the future. Understanding, agreement, and ownership are all outcomes of this method.

    The process is relatively simple. An initial session can take between two and three hours to complete, depending o
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    the amount of discussion that is a byproduct of the session.

    When to use it

    Obviously, you wouldn’t use this process for every marketing or communication project that comes across your desk. But for the larger ones, like branding your organ
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ization or major marketing campaigns, the addition of a process like this can save time and large amounts of resources in the long run, allowing you to avoid multiple expensive false starts.

    How it works

    There are three main parts of
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    the session:

    1.) determining where everyone stands at the start, in terms of understanding the objective and why it’s being undertaken

    2.) identifying everyone’s current perceptions regarding the objective, and

    3.) identifying
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    where the group wants to end up in terms of future perceptions for the initiative. After all of these elements are identified through exercises, discussion uncovers similarities and direction that can be agreed upon. These will be the basis for the
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    creative direction.

    The details

    2 to 3-hour working session
    Attended by everyone who has a voice in the outcome
    No more than 25, no less than 4 attendees
    Review of the structure of the session

    Baseline Brainstorming --
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    the group will participate in a working session to identify individual understanding of the objectives.

    Current and Desired Perceptions -- this two-part exercise helps to identify current and desired future perceptions of the initiative.

    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    >Emotional Tests -- The group “reacts” to common graphic and communication elements as they relate to previously defined desired future perceptions. The group rates and categorizes communication elements for appropriateness for the initiative.

    <
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    i>Summary and Review
    Progress and direction are reviewed
    Next steps defined

    Results Report and Creative Development
    Information gathered at this session is condensed and organized into a report for team approval of directio
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    n.
    After approval of results report, creative conceptualization is begun by design team.

    Group Assessment
    Group critiques creative solutions
    Direction approved, or
    Feedback is given for further development

    When embarking
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    on major marketing or branding campaigns, organizations that take the time to lay the groundwork with this critical process will pave the way for group buy-in, saving time and large amounts of resources. It’s all about helping people make connections


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/26330/justotherarticles-How-to-Get-BuyIn-for-Important-Marketing-and-Branding-Initiatives.html">How to Get Buy-In for Important Marketing and Branding Initiatives</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/26330/justotherarticles-How-to-Get-BuyIn-for-Important-Marketing-and-Branding-Initiatives.html]How to Get Buy-In for Important Marketing and Branding Initiatives[/url]

    Related Articles:

    Payroll Cards Improve Direct Deposit Participation

    Sound is a Sound Reason for Business Success! How to Get Rich in Any Business?

    Keeping Employees For The Long Run- Employee Retention

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com